These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11937086)

  • 1. Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?
    Terrón JA
    Eur J Pharmacol; 2002 Mar; 439(1-3):1-11. PubMed ID: 11937086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
    Peroutka SJ
    Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine: current therapeutic targets and future avenues.
    Arulmozhi DK; Veeranjaneyulu A; Bodhankar SL
    Curr Vasc Pharmacol; 2006 Apr; 4(2):117-28. PubMed ID: 16611154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and biomolecular identification of 5-HT₇ receptor in rat vestibular nuclei.
    Khalmuratova R; Hah YS; Ahn SK; Jeon SY; Kim JP; Balaban CD
    J Vestib Res; 2010; 20(6):401-6. PubMed ID: 21248402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine and its role in migraine.
    Lance JW
    Eur Neurol; 1991; 31(5):279-81. PubMed ID: 1884718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Migraine and irritable bowel syndrome].
    Mulak A; Paradowski L
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S55-60. PubMed ID: 16419571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
    Villalón CM; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine and the pathophysiology of migraine.
    Humphrey PP
    J Neurol; 1991; 238 Suppl 1():S38-44. PubMed ID: 2045830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
    Bánk J
    Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives.
    Fozard JR; Kalkman HO
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):225-9. PubMed ID: 7824037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
    Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
    Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine and its putative aetiological involvement in migraine.
    Lance JW; Lambert GA; Goadsby PJ; Zagami AS
    Cephalalgia; 1989; 9 Suppl 9():7-13. PubMed ID: 2661013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation.
    Pierce PA; Xie GX; Peroutka SJ; Levine JD
    Reg Anesth; 1996; 21(3):219-25. PubMed ID: 8744664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of extravascular serotonin receptors in the brain.
    Haigler HJ
    Adv Neurol; 1982; 33():283-9. PubMed ID: 7055009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.